Ogiya Akiko, Iwase Takuji, Kitagawa Dai, Nakashima Eri, Sakai Takehiko, Miyagi Yumi, Iijima Kotaro, Morizono Hidetomo, Makita Masujiro, Horii Rie, Akiyama Futoshi
Department of Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
Department of Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
Breast. 2015 Aug;24(4):476-80. doi: 10.1016/j.breast.2015.04.009. Epub 2015 May 8.
One-step nucleic acid amplification (OSNA) examines lymph node metastasis in a semiquantitative manner with molecular biology techniques. In this study, we conducted a whole-node analysis of non-sentinel lymph nodes (SLNs) using the OSNA method in SLN metastasis-positive breast cancer patients.
With the OSNA method, we compared the rates of positivity of non-SLN metastasis in cases with both SLN micro- and macrometastases.
The rates of non-SLN metastasis positivity in those with SLN micrometastasis and macrometastasis were 44% and 48%, respectively, and this difference was not significant. When the study of non-SLN metastasis positivity was focused only on macrometastases, the rates of non-SLN metastasis positivity in patients with SLN micrometastasis and macrometastasis were 19% and 22%, respectively, and there was no significant difference.
Regardless of the copy number of SLN metastases, non-SLN metastases were found in approximately half of the cases.
